The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 89BIO INC | COM | 282559103 | BBG00QKDZ8J5 | 4,268,156 | 545,800 | SH | SOLE | 545,800 | 0 | 0 | ||
| ACELYRIN INC | COM | 00445A100 | BBG00YJKJ8H4 | 5,353,151 | 1,704,825 | SH | SOLE | 1,532,006 | 0 | 172,819 | ||
| ALKERMES PLC | SHS | G01767105 | BBG000C9F2F9 | 11,992,000 | 416,968 | SH | SOLE | 373,067 | 0 | 43,901 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 6,978,456 | 500,966 | SH | SOLE | 389,737 | 0 | 111,229 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG01QSRLDH1 | 330,625 | 575,000 | SH | Call | SOLE | 575,000 | 0 | 0 | |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG01QSRMNC3 | 250,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| ATYR PHARMA INC | COM NEW | 002120202 | BBG001J2P692 | 725,720 | 200,475 | SH | SOLE | 200,475 | 0 | 0 | ||
| BIOHAVEN LTD | COM | G1110E107 | BBG017BXV3Q9 | 6,962,526 | 186,413 | SH | SOLE | 162,810 | 0 | 23,603 | ||
| BIONTECH SE | SPONSORED ADS | 09075V102 | BBG00Q70B3V1 | 6,996,872 | 61,403 | SH | SOLE | 61,403 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | BBG000DQLV23 | 9,392,806 | 166,068 | SH | SOLE | 166,068 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | BBG01081FC59 | 10,752,897 | 641,964 | SH | SOLE | 573,052 | 0 | 68,912 | ||
| CIDARA THERAPEUTICS INC | COM NEW | 171757206 | BBG006R5MFT6 | 1,280,617 | 47,642 | SH | SOLE | 47,642 | 0 | 0 | ||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | BBG01M27SVP6 | 3,894,453 | 265,833 | SH | SOLE | 265,833 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | BBG00BC59224 | 16,211,278 | 317,060 | SH | SOLE | 301,686 | 0 | 15,374 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | BBG000F0R4N9 | 3,931,415 | 83,576 | SH | SOLE | 74,832 | 0 | 8,744 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | BBG008P7F869 | 11,908,605 | 584,328 | SH | SOLE | 507,792 | 0 | 76,536 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | BBG00K4Y2H24 | 3,543,250 | 132,706 | SH | SOLE | 132,706 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00CP3BDD4 | 2,176,110 | 96,716 | SH | SOLE | 96,716 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | BBG000F90JX5 | 4,317,275 | 579,500 | SH | SOLE | 579,500 | 0 | 0 | ||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | BBG01L3GYF02 | 2,109,450 | 200,900 | SH | SOLE | 200,900 | 0 | 0 | ||
| HIMS & HERS HEALTH INC | COM CL A | 433000106 | BBG01LX26WT3 | 75,000 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 27,705,443 | 1,118,508 | SH | SOLE | 967,134 | 0 | 151,374 | ||
| INCYTE CORP | COM | 45337C102 | BBG000BNPSQ9 | 13,373,541 | 193,623 | SH | SOLE | 180,478 | 0 | 13,145 | ||
| INSMED INC | COM PAR $.01 | 457669307 | BBG000BWM5P3 | 7,360,354 | 106,610 | SH | SOLE | 95,814 | 0 | 10,796 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | BBG01NYD3QN6 | 514,500 | 70,000 | SH | Put | SOLE | 70,000 | 0 | 0 | |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | BBG000FTLBV7 | 7,025,567 | 949,401 | SH | SOLE | 808,473 | 0 | 140,928 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | BBG00ZHSKH11 | 7,810,201 | 145,876 | SH | SOLE | 123,593 | 0 | 22,283 | ||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | BBG00QPZNP97 | 2,891,517 | 135,244 | SH | SOLE | 121,248 | 0 | 13,996 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | BBG0026ZG5B0 | 8,409,041 | 992,803 | SH | SOLE | 857,493 | 0 | 135,310 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 25,852,845 | 614,812 | SH | SOLE | 535,408 | 0 | 79,404 | ||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | BBG00ZXN1GN3 | 4,925,243 | 400,101 | SH | SOLE | 400,101 | 0 | 0 | ||
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | BBG012W9C4X1 | 4,538,252 | 428,137 | SH | SOLE | 367,299 | 0 | 60,838 | ||
| NUVALENT INC | COM | 670703107 | BBG00Z1SLMK5 | 11,368,918 | 145,234 | SH | SOLE | 125,401 | 0 | 19,833 | ||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | BBG01N0FG6L0 | 1,527,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | BBG00W9LF2G5 | 10,326,339 | 134,178 | SH | SOLE | 114,828 | 0 | 19,350 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | BBG002B63KM7 | 5,470,160 | 141,714 | SH | SOLE | 127,442 | 0 | 14,272 | ||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | BBG001ZLYSH5 | 1,755,040 | 332,394 | SH | SOLE | 332,394 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | BBG00829F4P8 | 8,465,221 | 193,535 | SH | SOLE | 172,148 | 0 | 21,387 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ601 | 11,644,736 | 208,016 | SH | SOLE | 184,054 | 0 | 23,962 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | BBG000WG3567 | 3,406,256 | 270,983 | SH | SOLE | 270,983 | 0 | 0 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | BBG007STW2B8 | 32,092,164 | 2,712,778 | SH | SOLE | 2,712,778 | 0 | 0 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | BBG00KT2RRM6 | 7,187,789 | 166,307 | SH | SOLE | 150,212 | 0 | 16,095 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | BBG01Q6QZF05 | 227,500 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | BBG019LF44C6 | 214,025 | 35,000 | SH | Put | SOLE | 35,000 | 0 | 0 | |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | BBG01RH7QCS0 | 199,750 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| SURROZEN INC | COM NEW | 86889P208 | BBG00XY94S95 | 5,030,723 | 350,573 | SH | SOLE | 289,789 | 0 | 60,784 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG000R33JY1 | 37,975,785 | 2,872,601 | SH | SOLE | 2,407,713 | 0 | 464,888 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG01JN3CNZ3 | 21,025 | 84,100 | SH | Call | SOLE | 84,100 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG01JN3CM03 | 30,000 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| TECTONIC THERAPEUTIC INC | COM | 878972108 | BBG00DJ4T7D1 | 435,568 | 9,434 | SH | SOLE | 9,434 | 0 | 0 | ||
| TOURMALINE BIO INC | COM | 89157D105 | BBG00NX995R3 | 2,563,392 | 126,400 | SH | SOLE | 126,400 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | BBG001RWPDW6 | 4,283,105 | 101,809 | SH | SOLE | 101,809 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | BBG005SSJYH3 | 1,589,400 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | BBG00GD4KBL1 | 1,306,636 | 28,136 | SH | SOLE | 28,136 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 897,148 | 616,749 | SH | SOLE | 616,749 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 5,049,642 | 1,711,743 | SH | SOLE | 1,437,093 | 0 | 274,650 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V54 | 8,921,355 | 721,209 | SH | SOLE | 654,639 | 0 | 66,570 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | BBG0073DM784 | 14,733,124 | 375,845 | SH | SOLE | 344,765 | 0 | 31,080 | ||